PEPTI lists NAD+ injection at $249 as recall touches category
A nationwide compounding recall covering one NAD+ vial puts sourcing and sterility documentation in front of buyers of injectable longevity peptides.
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 26 07:37 ETSource: PEPTI
The wire
- 01Apothecary Pharma's recall of 22 tirzepatide vials and one NAD+ vial was classified Class II this week, placing NAD+ in a category usually dominated by GLP-1 actions.
- 02PEPTI sells NAD+ injection at $249 per 28-day fill, with a 500 mg vial at $229, compounded at a US FDA-registered pharmacy and shipped cold.
- 03PEPTI publishes pharmacy certificates of analysis on its quality page; whether buyers now check lot-level documentation before ordering injectables remains unmeasured.
From the source
Read at hellopepti.comNAD+ injection pricing
Source URL https://hellopepti.com/cost/nad-injection
